The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: Light at the end of the tunnel?

Journal of the American Society of Nephrology

Volumn 23, Issue 2, 2012, Pages 189-191

  Zaritsky, Joshua J ^a,b   Kalantar Zadeh, Kamyar ^a,b,c  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BRADYKININ; C REACTIVE PROTEIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; INTERLEUKIN 6; PARATHYROID HORMONE; RAMIPRIL; SERUM ALBUMIN; TELMISARTAN;

BLOOD PRESSURE REGULATION; BONE DISEASE; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DEATH; DEMOGRAPHY; DISEASE COURSE; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEMODIALYSIS PATIENT; HUMAN; IMMUNOMODULATION; INFLAMMATION; LIFE EXPECTANCY; LONG TERM CARE; MALNUTRITION; OXIDATIVE STRESS; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTAKE; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SURVIVAL RATE; THROMBOCYTE ACTIVATION; THROMBOCYTOSIS;

EID: 84856871682     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011121208     Document Type: Editorial

References (18)

1. US Renal Data System (USRDS): USRDS 2011 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2011
2. Kalantar-Zadeh K, Cano NJ, Budde K, Chazot C, Kovesdy CP, Mak RH, Mehrotra R, Raj DS, Sehgal AR, Stenvinkel P, Ikizler TA: Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol 7: 369-384, 2011
3. Noori N, Kovesdy CP, Dukkipati R, Feroze U, Molnar MZ, Bross R, Nissenson AR, Kopple JD, Norris KC, Kalantar-Zadeh K: Racial and ethnic differences in mortality of hemodialysis patients: Role of dietary and nutritional status and inflammation. Am J Nephrol 33: 157-167, 2011
4. Feroze U, Noori N, Kovesdy CP, Molnar MZ, Martin DJ, Reina-Patton A, Benner D, Bross R, Norris KC, Kopple JD, Kalantar-Zadeh K: Quality-of-life and mortality in hemodialysis patients: Roles of race and nutritional status. Clin J Am Soc Nephrol 6: 1100-1111, 2011
5. Molnar MZ, Streja E, Kovesdy CP, Budoff MJ, Nissenson AR, Krishnan M, Anker SD, Norris KC, Fonarow GC, Kalantar-Zadeh K: High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. Am J Clin Nutr 94: 945-954, 2011
6. Kovesdy CP, Kalantar-Zadeh K: Do genes allow inflammation to kill or not to kill? J Am Soc Nephrol 20: 1429-1431, 2009
7. Kalantar-Zadeh K, Norris KC: Is the malnutrition-inflammation complex the secret behind greater survival of African-American dialysis patients? J Am Soc Nephrol 22: 2150-2152, 2011
8. Nascimento MM, Pecoits-Filho R, Lindholm B, Riella MC, Stenvinkel P: Inflammation, malnutrition and atherosclerosis in end-stage renal disease: A global perspective. Blood Purif 20: 454-458, 2002 (Pubitemid 35007560)
9. Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, Kalantar-Zadeh K: Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr 21: 100-104, 2011
10. Li GS, Chen XL, Zhang Y, He Q, Wang F, Hong DQ, Zhang P, Pu L, Zhang Y, Yang XC, Wang L: Malnutrition and inflammation in acute kidney injury due to earthquake-related crush syndrome. BMC Nephrol 11: 4, 2010
11. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G; Cholesterol and Recurrent Events (CARE) Trial Investigators: Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68: 237-245, 2005 (Pubitemid 43181381)
12. Zannad F, Kessler M, Lehert P, Grünfeld JP, Thuilliez C, Leizorovicz A, Lechat P: Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies. Kidney Int 70: 1318-1324, 2006 (Pubitemid 44435184)
13. Cice G, Di Benedetto A, D'Isa S, D'Andrea A, Marcelli D, Gatti E, Calabrò R: Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial. J Am Coll Cardiol 56: 1701-1708, 2010
14. Chan KE, Ikizler TA, Gamboa JL, Yu C, Hakim RM, Brown NJ: Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. Kidney Int 80: 978-985, 2011
15. Gamboa JL, Pretorius M, Todd-Tzanetos DR, Luther JM, Yu C, Ikizler TA, Brown NJ: Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis. J Am Soc Nephrol 23: 334-342, 2012
16. Kakoki M, McGarrah RW, Kim HS, Smithies O: Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc Natl Acad Sci USA 104: 7576-7581, 2007 (Pubitemid 47185948)
17. Kakoki M, Smithies O: The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int 75: 1019-1030, 2009
18. Crews DC, Sozio SM, Liu Y, Coresh J, Powe NR: Inflammation and the paradox of racial differences in dialysis survival. J Am Soc Nephrol 22: 2279-2286, 2011